The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 53 | — | 20.1x | Near average | |
Growth | 21 | — | 5.6% | Below average | |
Quality | 49 | 224.6% | 7.6% | Near average | |
Safety | 19 | 0.7x | 0.4x | Below average | |
Capital Return | 38 | — | 2.19% | Near average | |
Momentum | 90 | — | — | Above average | |
Sentiment | 31 | — | — | Below average |
COMPASS Pathways plc is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy COMPASS Pathways plc shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
CMPS stock has seen stability in its average price target at $18.13, with a slight increase of 0.72% over the last thirty days. However, a decrease in the number of analysts contributing to the forecasts from 6 to 4 analysts has been noted recently, indicating a decline in active research coverage or anticipation of new clinical results. The gap between the low ($15) and high ($22) reflects a moderate variance in estimates, but all remain above the current price ($11.81).
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.